Characterization of steroid-binding sites by affinity-labeling. II. Biological activity of 4-mercuri-17 beta-estradiol.
D000429:Alcohol Oxidoreductases / Q000096:biosynthesis*; D000818:Animals; D001565:Benzoates / Q000494:pharmacology; D001665:Binding Sites; D002369:Castration; D055598:Chemical Phenomena; D002621:Chemistry; D004717:Endometrium / Q000166:cytology; D004790:Enzyme Induction; D004958:Estradiol / Q000494:pharmacology*; D004962:Estranes / Q000378:metabolism / Q000494:pharmacology*; D004967:Estrogens / Q000494:pharmacology; D005260:Female; D005942:Gluconates; D005954:Glucosephosphate Dehydrogenase / Q000096:biosynthesis*; D006003:Glycogen / Q000096:biosynthesis; D008623:Mercaptoethanol; D008628:Mercury / Q000494:pharmacology*; D010053:Ovary / Q000502:physiology; D051381:Rats; D011955:Receptors, Drug; D012995:Solubility; D013268:Stimulation, Chemical; D013997:Time Factors; D014599:Uterus / Q000201:enzymology / Q000378:metabolism*
D001565:Benzoates; D004962:Estranes; D004967:Estrogens; D005942:Gluconates; D011955:Receptors, Drug; D004958:Estradiol; D008623:Mercaptoethanol; D006003:Glycogen; D000429:Alcohol Oxidoreductases; D005954:Glucosephosphate Dehydrogenase; D008628:Mercury